nafcillin has been researched along with daptomycin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Gristina, A; Myrvik, QN; Naylor, PT | 1 |
Beaudette, F; Benson, CA; Trenholm, G | 1 |
LaPlante, KL; Rybak, MJ | 1 |
Alder, JD; Mascio, CT; Silverman, JA | 1 |
Rybak, MJ; Steed, ME; Vidaillac, C | 1 |
Bland, CM; Bookstaver, PB; Riser, MS; Rudisill, CN | 1 |
Chanda, PK; Mehta, S; Paul, A; Plata, KB; Riosa, S; Rosato, AE; Rosato, RR; Singh, C | 1 |
Leonard, SN; Rolek, KM | 1 |
Bayer, AS; Dam, Q; Dhand, A; Hensler, ME; Nizet, V; Nonejuie, P; Okumura, CY; Olson, J; Pogliano, J; Sakoulas, G; Thienphrapa, W; Yeaman, MR | 1 |
Berti, AD; Nizet, V; Nonejuie, P; Olson, J; Pogliano, J; Proctor, RA; Rose, WE; Sakoulas, G; Sauer, JD; Theisen, E | 1 |
Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
Catteau, L; Iglesias, YD; Nizet, V; Pogliano, J; Sakoulas, G; Tsunemoto, H; Van Bambeke, F | 1 |
12 other study(ies) available for nafcillin and daptomycin
Article | Year |
---|---|
Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocompatible Materials; Cefazolin; Coagulase; Daptomycin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1990 |
Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Penicillin Resistance; Peptides; Vancomycin | 1987 |
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Culture Media; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Half-Life; Kinetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillins; Staphylococcus aureus; Vancomycin | 2004 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
Topics: Acetamides; Anti-Infective Agents; Cefepime; Cephalosporins; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Male; Meningitis, Bacterial; Methicillin; Middle Aged; Nafcillin; Nephritis, Interstitial; Recurrence; Staphylococcal Infections; Staphylococcus aureus | 2010 |
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Daptomycin; DNA; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Insecta; Larva; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Nafcillin; Oxacillin; Staphylococcal Infections | 2012 |
Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Computer Simulation; Daptomycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Microbial Viability; Nafcillin; Staphylococcus aureus; Vancomycin Resistance | 2013 |
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Cathelicidins; Cell Line; Cells, Cultured; Daptomycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Keratinocytes; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Viability; Middle Aged; Nafcillin; Neutrophils; Phagocytosis; Staphylococcal Infections | 2014 |
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy.
Topics: Anti-Bacterial Agents; Cefaclor; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Bacterial; Imipenem; Meropenem; Methicillin-Resistant Staphylococcus aureus; Models, Statistical; Nafcillin; Penicillin-Binding Proteins; Promoter Regions, Genetic; Protein Isoforms; Thienamycins; Transcription, Genetic | 2016 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis.
Topics: Anti-Bacterial Agents; Cathelicidins; Ceftaroline; Daptomycin; Endocarditis; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Staphylococcus epidermidis | 2023 |